These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20210122)

  • 1. U.S. Congress to consider vaccine-focused legislation.
    IAVI Rep; 2007; 11(1):19. PubMed ID: 20210122
    [No Abstract]   [Full Text] [Related]  

  • 2. Stalled vaccine effort gets new boost in U.S.
    AIDS Alert; 1997 Jul; 12(7):73-5. PubMed ID: 11364394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIAID and Merck to collaborate on HIV vaccine development.
    AIDS Read; 2002 Feb; 12(2):60. PubMed ID: 11905140
    [No Abstract]   [Full Text] [Related]  

  • 4. Can advocates keep congress focused on HIV?
    AIDS Alert; 2001 Dec; 16(12):157-8. PubMed ID: 11768874
    [No Abstract]   [Full Text] [Related]  

  • 5. NIAID collaborates with VaxGen on vaccine studies.
    AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
    [No Abstract]   [Full Text] [Related]  

  • 6. Tripping over trips and the global HIV/AIDS epidemic: legislation and political decisions in Brazil and the United States.
    Emilio AB
    J Contemp Health Law Policy; 2011; 28(1):57-85. PubMed ID: 22292321
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine legislation.
    AIDS Policy Law; 1999 Jul; 14(13):16. PubMed ID: 11366597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An HIV vaccine: as we build it, will they come?
    McCluskey MM; Alexander SB; Larkin BD; Murguia M; Wakefield S
    Health Aff (Millwood); 2005; 24(3):643-51. PubMed ID: 15886155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First large-scale U.S. trial of HIV vaccine begins soon.
    AIDS Policy Law; 1998 Jun; 13(12):10. PubMed ID: 11365517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aches and pains. Learning lessons from the influenza vaccine shortage.
    Fink S
    IAVI Rep; 2004 Dec-2005 Mar; 9(1):10-1. PubMed ID: 16110570
    [No Abstract]   [Full Text] [Related]  

  • 11. Congress considers coordinated, global approach against AIDS/HIV.
    AIDS Policy Law; 2001 Aug; 16(15):1-2. PubMed ID: 11548388
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV vaccine best hope for controlling AIDS, says NNIH.
    AIDS Policy Law; 2002 Jun; 17(11):2. PubMed ID: 12083036
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV vaccine holds promise of global effectiveness.
    J Calif Dent Assoc; 2003 Jan; 31(1):13. PubMed ID: 12583445
    [No Abstract]   [Full Text] [Related]  

  • 14. New branch created by the NIAID to promote HIV vaccine development.
    Expert Rev Vaccines; 2008 Aug; 7(6):709. PubMed ID: 18665768
    [No Abstract]   [Full Text] [Related]  

  • 15. Advocacy group sees little progress toward an HIV vaccine.
    AIDS Policy Law; 1998 May; 13(10):1, 8-9. PubMed ID: 11365444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIAID funds center for HIV/AIDS vaccine immunology.
    AIDS Policy Law; 2005 Jul; 20(14):2. PubMed ID: 16108120
    [No Abstract]   [Full Text] [Related]  

  • 17. International patent protection for HIV-related therapies: patent attorney's perspective.
    Pavento LC; Greene JL; McDonald JK
    Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
    [No Abstract]   [Full Text] [Related]  

  • 18. CEL-SCI offers South Africa a free license to use AIDS vaccine.
    AIDS Read; 2000 Jun; 10(6):340. PubMed ID: 10881364
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmexa-Epimmune and Bavarian Nordic begin AIDS vaccine trial.
    IAVI Rep; 2007; 11(2):15. PubMed ID: 20210117
    [No Abstract]   [Full Text] [Related]  

  • 20. Africa treatment access: contact president, congress on Africa executive order.
    James JS
    AIDS Treat News; 2001 Jan; (359):6-7. PubMed ID: 12173563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.